Nutra Pharma Corp (NPHC)

[Tlsmd]

Hi goarmy2020, I just got on board and see the news. I saw it elsewhere also. Wiill see if I can put up what I saw. This is what was put out by the service. Tlsmd

Awesome Stock Tips
Mega Alert: NPHC
Good Morning,

NPHC just dropped the mother of all news...

Nutra Pharma Announces Collaboration with the
International Security Group for Development
of Nerve Agent Counter Measures

"We have long worked with neuroactive compounds utilized in our drugs
for the treatment of neurological diseases like Multiple Sclerosis," stated
Rik J Deitsch, Chief Executive Officer of Nutra Pharma.

"In much the same way that our therapies protect the nerves of patients
with disease, our findings indicate that we may protect against -- or at
least mitigate the damage caused by -- nerve agents that are utilized as
chemical weapons" he continued.

"We are working on new intellectual property surrounding these findings
and expect to have our products in testing shortly," he concluded.

Nerve Agent attacks have been on the rise in the past years and NPHC
is at the forefront of the technology to counter such horrific weapons.

"Counter measures for organophosphate nerve agents such as VX
and Sarin remain a troubling threat to American service people and
civilians as evidenced by the recent attacks in Syria and Malaysia,"

It appears NPHC is on the forefront of these new countermeasures which
could provide them with not only substantial revenue generating contracts
but IP patents for new products for security and US Gov.


NPHC is one of a few sub penny's with a ratings.

NPHC specializes in pharma products and technology for:

Neurological Disorders
Cancer
Autoimmune Disorders
Infectious diseases
Multiple Sclerosis
Human Immunodeficiency Virus (HIV)
Adrenomyeloneurapathy (AMN)
Pain Management.
Currently, Nutra Pharma offers several Pharma products for sale for the
treatment of pain: Nyloxin®, the first over-the-counter (OTC) pain reliever
clinically proven to treat moderate to severe (Stage 2) chronic pain, and
Nyloxin Extra Strength, the only non-narcotic and non-addictive
treatment for severe (Stage 3) pain.

Nyloxin® is protected under patent #7,902,152, Use of cobratoxin as an
analgesic.

In December of 2014, the Company launched Pet Pain-Away - the first
OTC product to treat pain in companion animals without side effects.

The moment you put Patent and Pharma in the same sentence, investors
tend to flock rapidly to grab their positions.

Nutra Pharma has completed pre-clinical and animal models for their MS
and HIV applications and are preparing to move into pivotal Phase II
trials.

Nutra Pharma's MS drug was recently granted Orphan Status by
the FDA for the treatment of Pediatric Multiple Sclerosis

So....This is where it gets interesting...

NPHC uses Cobra Venom for treatment
of pain... NBC News Miami aired an
interview with CEO Rick Deitsch on this
ancient method that is making a
modern comeback.

At the end of 2016, NPHC CEO issued a letter to share holders which
clearly paints the picture of why their chart is in a bullish formation:

RSI - Right on the oversold line, VERY BULLISH
Price - Under support line, 52Week LOWS. Bullish
MACD - Far under zero line, in a bullish set up.
Acc/Dist - Trending up from bottom levels. Bullish

I hope now you are starting to get a better picture of why NPHC is
on high alert, sitting on 52Week lows, packing fundamentals that
could rival some big board pharma companies and could become
a multi-week monster.

Start your research on NPHC right away and enjoy.

Sincerely,

AST



DISCLAIMER

We have r.eceived five thsnd dlrs via a b.ank w.ire for the a.wareness of NPHC


Disclaimer- By reading our newsletter you agree to the terms of our disclaimer, which are subject to change at any time. Owners and affiliates are not registered or licensed in any jurisdiction whatsoever to provide financial advice or anything of an advisory nature. Always do your own research and/or consult with an investment professional before investing. Low priced stocks are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold us, our editor's, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters, website, twitter, Facebook and chat. We do not advise any reader take any specific action. Our website, newsletter, twitter, Facebook and chat are for informational and educational purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter, twitter, Facebook and on our website may be based on EOD or intraday data. We may be c.ompensated for the production, release and awareness of this newsletter. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. Our emails may contain Forward Looking Statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters, twitter, Facebook our website and chat is believed to be accurate and correct, but has not been independently verified. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at www.awesomestocktips.com/disclaimer
We are not held liable or responsible for the information in press releases issued by the companies discussed in these email's. Please do your own due diligence.
This message sent to [e-mail] from [e-mail]

Awesome Stock Tips
The Staff
7111 W 151 St. #287
Overland Park, Kansas 66223-2231
Unsubscribe